Copyright © 1994 by the European Society of Cardiology.
Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
ON BEHALF OF THE TASK FORCE, K. PYÖRÄLÄ, G. DE BACKER, I. GRAHAM, P. POOLE-WILSON, and D. WOOD
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. E van der Elst, M. L Bouvy, C. J de Blaey, and A. de Boer Effect of drug combinations on admission for recurrent myocardial infarction Heart, October 1, 2007; 93(10): 1226 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wood The concept of doctor targets based on quality guidelines: focus on blood pressure Eur. Heart J. Suppl., May 1, 2007; 9(suppl_B): B29 - B36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Cubbon, S. B. Wheatcroft, P. J. Grant, C. P. Gale, J. H. Barth, R. J. Sapsford, R. Ajjan, M. T. Kearney, A. S. Hall, and on behalf of the EMMACE (Evaluation of Methods and Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003 Eur. Heart J., March 1, 2007; 28(5): 540 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Benn, B. G. Nordestgaard, G. B. Jensen, and A. Tybjaerg-Hansen Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B: The Copenhagen City Heart Study Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 661 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Scholte op Reimer, E. de Swart, D. De Bacquer, K. Pyorala, U. Keil, J. Heidrich, J. W. Deckers, K. Kotseva, D. Wood, E. Boersma, et al. Smoking behaviour in European patients with established coronary heart disease Eur. Heart J., January 1, 2006; 27(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Confalonieri, G. Garuti, M. S. Cattaruzza, J. F. Osborn, M. Antonelli, G. Conti, M. Kodric, O. Resta, S. Marchese, C. Gregoretti, et al. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation Eur. Respir. J., February 1, 2005; 25(2): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tolonen, U. Keil, M. Ferrario, A. Evans, and for the WHO MONICA Project Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project Int. J. Epidemiol., February 1, 2005; 34(1): 181 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk Ann Intern Med, September 21, 2004; 141(6): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Castano, R. Mas, R. Gamez, L. Fernandez, and J. Illnait Effects of Policosanol and Ticlopidine in Patients with Intermittent Claudication: A Double-Blinded Pilot Comparative Study Angiology, July 1, 2004; 55(4): 361 - 371. [Abstract] [PDF]
|
|
|
|
|
|
F.D.R. Hobbs Guidelines and management of global risk: the European perspective Eur. Heart J. Suppl., July 1, 2004; 6(suppl_C): C5 - C14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Smith Jr, R. Jackson, T. A. Pearson, V. Fuster, S. Yusuf, O. Faergeman, D. A. Wood, M. Alderman, J. Horgan, P. Home, et al. Principles for National and Regional Guidelines on Cardiovascular Disease Prevention: A Scientific Statement From the World Heart and Stroke Forum Circulation, June 29, 2004; 109(25): 3112 - 3121. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, Y. Hong, R. B. D'Agostino Sr, Z. Wu, W. Wang, J. Sun, P. W. F. Wilson, W. B. Kannel, and D. Zhao Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared With the Chinese Multi-provincial Cohort Study JAMA, June 2, 2004; 291(21): 2591 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ulbak, L. Lauritzen, H. S Hansen, and K. F Michaelsen Diet and blood pressure in 2.5-y-old Danish children Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1095 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nolan, G.F. Watts, S.E. Herrmann, M.A. French, M. John, and S. Mallal Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk? QJM, November 1, 2003; 96(11): 825 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K Lewis, J. Robinson, and E. Wilkinson Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes BMJ, October 11, 2003; 327(7419): 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. De Bacquer, P. Ducimetiere, P. Jousilahti, U. Keil, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur. Heart J., June 1, 2003; 24(11): 987 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kadikoylu, V. Yukselen, I. Yavasoglu, and Z. Bolaman Hemostatic Effects of Atorvastatin Versus Simvastatin Ann. Pharmacother., April 1, 2003; 37(4): 478 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Budzynski, M. Klopocka, M. Swiatkowski, G. Pulkowski, and M. Ziolkowski LIPOPROTEIN(a) IN ALCOHOL-DEPENDENT MALE PATIENTS DURING A SIX-MONTH ABSTINENCE PERIOD Alcohol Alcohol., March 1, 2003; 38(2): 157 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.H Hennekens Screening individuals and families with premature coronary heart disease: a clinical and public health challenge Eur. Heart J., February 1, 2003; 24(3): 212 - 213. [Full Text] [PDF]
|
|
|
|
|
|
J De Sutter, D De Bacquer, K Kotseva, S Sans, K Pyorala, D Wood, G De Backer, and on behalf of the EUROASPIRE II study group Screening of family members of patients with premature coronary heart disease: Results from the EUROASPIRE II family survey Eur. Heart J., February 1, 2003; 24(3): 249 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D A Lawlor, C Bedford, M Taylor, and S Ebrahim Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study J. Epidemiol. Community Health, February 1, 2003; 57(2): 134 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. W. Umans-Eckenhausen, J. C. Defesche, M. J. van Dam, and J. J. P. Kastelein Long-term Compliance With Lipid-Lowering Medication After Genetic Screening for Familial Hypercholesterolemia Arch Intern Med, January 13, 2003; 163(1): 65 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E van der Elst, N. Cisneros-Gonzalez, C. J de Blaey, H. Buurma, and A. de Boer Oral Antithrombotic Use Among Myocardial Infarction Patients Ann. Pharmacother., January 1, 2003; 37(1): 143 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wood Guidelines and global risk: a European perspective Eur. Heart J. Suppl., September 1, 2002; 4(suppl_F): F12 - F18. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Gomez-Cerezo, J. J. Rios Blanco, I. Suarez Garcia, P. Moreno Anaya, P. Garcia Raya, E. Vazquez-Munoz, and F. J. Barbado Hernandez Noninvasive Study of Endothelial Function in White Coat Hypertension Hypertension, September 1, 2002; 40(3): 304 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Lorant, B Boland, P Humblet, and D Deliege Equity in prevention and health care J. Epidemiol. Community Health, July 1, 2002; 56(7): 510 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.E. Otterstad, M.G. St. John Sutton, G.S. Froeland, I. Holme, T. Skjaerpe, and C. Hall Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function Eur. Heart J., July 1, 2002; 23(13): 1011 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Law and N J Wald Risk factor thresholds: their existence under scrutiny BMJ, June 29, 2002; 324(7353): 1570 - 1576. [Full Text] [PDF]
|
|
|
|
|
|
K G M Moons, M L Bots, J T Salonen, P C Elwood, A Freire de Concalves, Y Nikitin, J Sivenius, D Inzitari, V Benetou, J Tuomilehto, et al. Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography? J. Epidemiol. Community Health, February 1, 2002; 56(90001): i30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Simon and H. Rosolova Predicting the coronary risk in primary and secondary prevention. What is the difference? Eur. Heart J., November 2, 2001; 22(22): 2047 - 2049. [PDF]
|
|
|
|
|
|
L. Ryden, M.L. Simoons, and J.P. Bassand Partnership in cardiovascular medicine. A key to success not only for professional organizations Eur. Heart J., October 2, 2001; 22(20): 1839 - 1843. [PDF]
|
|
|
|
 |
|
 D. Wood Asymptomatic individuals - risk stratification in the prevention of coronary heart disease Br. Med. Bull., October 1, 2001; 59(1): 3 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F McHugh, G M Lindsay, P Hanlon, I Hutton, M R Brown, C Morrison, and D J Wheatley Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial Heart, September 1, 2001; 86(3): 317 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rosolova and J. Simon Are the data on trends in case-fatality in patients with acute myocardial infarction observed in Scotland applicable across Europe? Eur. Heart J., June 2, 2001; 22(12): 979 - 980. [PDF]
|
|
|
|
|
|
C Hengstenberg, S.R Holmer, B Mayer, S Engel, A Schneider, H Lowel, G.A.J Riegger, and H Schunkert Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease Eur. Heart J., June 1, 2001; 22(11): 926 - 933. [Abstract] [PDF]
|
|
|
|
|
|
T.D. Barringer Dietary fats in the prevention of coronary heart disease: the need for more clinical trials Eur. Heart J. Suppl., June 1, 2001; 3(suppl_D): D79 - D84. [Abstract] [PDF]
|
|
|
|
|
|
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme Eur. Heart J., April 1, 2001; 22(7): 554 - 572. [Abstract] [PDF]
|
|
|
|
|
|
K. Orth-Gomer Coronary risk factor modification after the acute event--why are effects not maintained? Eur. Heart J., February 2, 2001; 22(4): 276 - 279. [PDF]
|
|
|
|
|
|
S.N Willich, J Muller-Nordhorn, M Kulig, S Binting, H Gohlke, H Hahmann, K Bestehorn, K Krobot, and H Voller Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort study Eur. Heart J., February 2, 2001; 22(4): 307 - 313. [Abstract] [PDF]
|
|
|
|
|
|
O. Simell, H. Niinikoski, T. Ronnemaa, H. Lapinleimu, T. Routi, H. Lagstrom, P. Salo, E. Jokinen, and J. Viikari Special Turku Coronary Risk Factor Intervention Project for Babies (STRIP) Am. J. Clinical Nutrition, November 1, 2000; 72 (5): 1316S - 1331S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stevinson, M. H. Pittler, and E. Ernst Garlic for Treating Hypercholesterolemia: A Meta-Analysis of Randomized Clinical Trials Ann Intern Med, September 19, 2000; 133(6): 420 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Menotti, M Lanti, P E Puddu, and D Kromhout Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart Heart, September 1, 2000; 84(3): 238 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H Korhonen, R. M. Jarvinen, E. S Sarkkinen, and M. I. Uusitupa Effects of a salt-restricted diet on the intake of other nutrients Am. J. Clinical Nutrition, August 1, 2000; 72(2): 414 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.C Lampe, P.H Whincup, S.G Wannamethee, A.G Shaper, M Walker, and S Ebrahim The natural history of prevalent ischaemic heart disease in middle-aged men Eur. Heart J., July 1, 2000; 21(13): 1052 - 1062. [Abstract] [PDF]
|
|
|
|
|
|
L. Papoz, A. Ponton, P. Segond, F. Becker, L. Drouet, J. Levenson, M. Marazanof, Y. Sentou, E. Chollet, J. Etiemble, et al. Feasibility and Reliability of Ankle/Arm Blood Pressure Index in Preventive Medicine Angiology, June 1, 2000; 51(6): 463 - 471. [Abstract] [PDF]
|
|
|
|
 |
|
 S.D. Oliver The long-term safety and tolerability of ispaghula husk The Journal of the Royal Society for the Promotion of Health, June 1, 2000; 120(2): 107 - 111. [Abstract] [PDF]
|
|
|
|
|
|
M. Montaye, D. De Bacquer, G. De Backer, and P. Amouyel Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe Eur. Heart J., May 2, 2000; 21(10): 808 - 813. [Abstract] [PDF]
|
|
|
|
|
|
R Erbel, A Schmermund, S Mohlenkamp, S Sack, and D Baumgart Electron-beam computed tomography for detection of early signs of coronary arteriosclerosis Eur. Heart J., May 1, 2000; 21(9): 720 - 732. [PDF]
|
|
|
|
|
|
S. Ulrich, A. D Hingorani, J. Martin, and P. Vallance What is the optimal age for starting lipid lowering treatment? A mathematical model BMJ, April 22, 2000; 320(7242): 1134 - 1140. [Full Text]
|
|
|
|
|
|
K. Pyorala Assessment of coronary heart disease risk in populations with different levels of risk Eur. Heart J., March 1, 2000; 21(5): 348 - 350. [PDF]
|
|
|
|
|
|
A Menotti, P.E Puddu, and M Lanti Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study Eur. Heart J., March 1, 2000; 21(5): 365 - 370. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Wierzbicki Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus Lupus, March 1, 2000; 9(3): 194 - 201. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Grundy, T. Bazzarre, J. Cleeman, R. B. D’Agostino Sr, M. Hill, N. Houston-Miller, W. B. Kannel, R. Krauss, H. M. Krumholz, R. M. Lauer, et al. Prevention Conference V : Beyond Secondary Prevention : Identifying the High-Risk Patient for Primary Prevention : Medical Office Assessment : Writing Group I Circulation, January 4, 2000; 101 (1): e3 - e11. [Full Text] [PDF]
|
|
|
|
|
|
J. Budzynski, J. Rybakowski, M. Swiatkowski, L. Torlinski, M. Klopocka, W. Kosmowski, and M. Ziolkowski NALTREXONE EXERTS A FAVOURABLE EFFECT ON PLASMA LIPIDS IN ABSTINENT PATIENTS WITH ALCOHOL DEPENDENCE Alcohol Alcohol., January 1, 2000; 35(1): 91 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.F.M. Van Berkel, H. Boersma, D. De Baquer, J.W. Deckers, and D. Wood Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey Eur. Heart J., November 2, 1999; 20(22): 1630 - 1637. [Abstract] [PDF]
|
|
|
|
|
|
D M Pickin, C J McCabe, L E Ramsay, N Payne, I U Haq, W W Yeo, and P R Jackson Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment Heart, September 1, 1999; 82(3): 325 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.J. Dunn, C.J. Burton, and T.G. Feest The care of patients with diabetic nephropathy: audit, feedback, and improvement QJM, August 1, 1999; 92(8): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Assmann, P. Cullen, F. Jossa, B. Lewis, and M. Mancini Coronary Heart Disease: Reducing the Risk : The Scientific Background to Primary and Secondary Prevention of Coronary Heart DiseaseA Worldwide View Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1819 - 1824. [Full Text] [PDF]
|
|
|
|
 |
|
 F. van Kooten, G. Ciabattoni, P. J. Koudstaal, D. E. Grobbee, C. Kluft, and C. Patrono Increased Thromboxane Biosynthesis Is Associated With Poststroke Dementia Stroke, August 1, 1999; 30(8): 1542 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.U. Haq, L.E. Ramsay, P.R. Jackson, and E.J. Wallis Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods QJM, July 1, 1999; 92(7): 379 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|